Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Fraud & Abuse, False Claims Act Counseling & Litigation

See All Services Meet The Team

Overview

Failing to comply with fraud and abuse laws can be both financially and reputationally damaging. Our attorneys, consultants and other professionals provide the guidance you need to avoid these high-stakes missteps — and to resolve them quickly when incidents emerge. We counsel on Stark Law, Anti-Kickback Statute and False Claims Act compliance, facilitate repayments when necessary, and help you respond to and defend against federal and state health care fraud, qui tam, whistleblower and False Claims Act lawsuits and government enforcement actions. We have extensive compliance, settlement and litigation experience with state and federal health programs, and our work has helped shape case law in these areas.

Insights & Events

Latest

Published Articles May 2025

The Booming Business of Botox: Legal Considerations for Medical Spas

2 min read  
Updates May 2025

DOJ National Security Division Issues Second Declination Since Issuance of Revised Corporate Enforcement Policy

Underscores Potential Benefits of Proactively Addressing and Disclosing Compliance Issues
7 min read  
Updates April 2025

Federal Court Strikes Down CMS Nursing Home Staffing Mandate

What’s Next for Operators & Investors?
5 min read  
Updates April 2025

Trump 2.0 — The Return of Tariff Uncertainty in Commercial Contracts

Identifying Vulnerabilities and Opportunities for Renegotiation
6 min read  
Published Articles April 2025

Lincoln’s Law Ascendant? Criminal Enforcement and the False Claims Act

1 min read  
Speaking Engagement Recap February 12, 2025

Evaluating Compliance and Ethics Programs in Senior Living and Care

LeadingAge Minnesota 2025 Institute & Expo
1 min read  
Press Release September 2024

Faegre Drinker Litigation Practice Continues to Grow With Addition of Experienced Commercial Litigator Eli Burriss

2 min read  
Press Release September 2024

Three Former Federal Prosecutors Join Faegre Drinker’s White Collar Team

5 min read  
Speaking Engagement Recap April 27, 2023

Addenda, One-Way Chart Reviews and Other Trends in Upcoding Lawsuits - Webinar

Virtual Fourth National Medicare Advantage Summit
1 min read  
Recorded Webinar June 09, 2021

Substance Use Disorder Treatment Centers: Uncovering Fraud and Advancing Policies to Promote Best Practices - Webinar

3 min read  
Insights
Published Articles May 2025

The Booming Business of Botox: Legal Considerations for Medical Spas

2 min read  
Updates May 2025

DOJ National Security Division Issues Second Declination Since Issuance of Revised Corporate Enforcement Policy

Underscores Potential Benefits of Proactively Addressing and Disclosing Compliance Issues
7 min read  
Updates April 2025

Federal Court Strikes Down CMS Nursing Home Staffing Mandate

What’s Next for Operators & Investors?
5 min read  
Updates April 2025

Trump 2.0 — The Return of Tariff Uncertainty in Commercial Contracts

Identifying Vulnerabilities and Opportunities for Renegotiation
6 min read  
Published Articles April 2025

Lincoln’s Law Ascendant? Criminal Enforcement and the False Claims Act

1 min read  
Updates March 2025

Heightened False Claims Act Enforcement of Customs and Trade Violations

Most FCA Matters Are Triggered by Whistleblowers
8 min read  
Updates March 2025

The Latest on Pharmaceutical Company-Sponsored Diagnostic Testing Programs

OIG’s Second Favorable Opinion Regarding Free Genetic Testing and Counseling: Advisory Opinion No. 24-12
8 min read  
Published Articles March 2025

Public Corruption & Public Confidence: Fewer Crimes and More Distrust in Government

2 min read  
Updates February 2025

China Issues Final Compliance Guidelines in Regulating the Medical Industry

Compliance Guidelines on Preventing Commercial Bribery Risks for Pharmaceutical Enterprises
7 min read  
Published Articles December 2024

Trump Administration Will Impact Agenda of State Attorneys General

Thomson Reuters
2 min read